Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Jeena Sikho Lifecare Investor Presentation: Key Takeaways

JSLL reported Q1FY27 revenue of Rs 224.4 Cr (+29% YoY) with an EBITDA margin of 41%. The company is expanding its integrated Ayurveda model across 2,400 operational beds.

Highlights
Revenue growth29% YoY Q1FY27
MarginsEBITDA margin 41%; Gross margin 89%
Demand visibility33% YoY IPD increase; 10M+ social media followers
Management confidenceStrong momentum in both services and products

Growth

Revenue grew 29% YoY; PAT increased 28% YoY to Rs 65.7 Cr. Healthcare products saw 47% YoY growth.

Outlook

Adding 450 beds in pipeline; 12-18 month payback for 100-bed facilities; targeting new plant-based protein and joint care launches.

Risks

High dependence on founder's social media funnel; transition to Ind AS accounting standards.

Last quarter's promises, checked

Delivered

  • Guided 2,800-3,000 beds in 3-4 months → Delivered 2,400 operational + 450 in pipeline (= BEAT)
  • Guided 50-50 revenue mix → Delivered 53% products / 47% services (= BEAT)
  • Guided 44-46% EBITDA margin → Delivered 41% Q1FY27 (= PARTIAL)

Partly delivered

  • Guided 4x-5x PAT growth over 4 years → Q1FY27 PAT +28% YoY (= PARTIAL)
Source

Investor Presentation filed with BSE, NSE: JSLL. Summary written with AI assistance from the document.

Read the document ↗

Jeena Sikho Lifecare Ltd: key numbers

Share price
₹508.25
Market cap
₹6,318 Cr
Revenue (annual)
₹801.4 Cr
Net profit (annual)
₹221.8 Cr
P/E (TTM)
26.7×Sector 50.4×
Promoter holding
63.62%+0.00% QoQ
FII holding
4.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jeena Sikho Lifecare Ltd

All →
12:22 IST BSE
Employee Stock Options

Jeena Sikho Lifecare Employee Stock Options

Jeena Sikho Lifecare received BSE in-principle approval to list up to 6,50,000 ESOS 2024 shares. Both NSE and BSE approvals are now in place.

18:36 IST BSE
Product Launch

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare has launched two new Ayurvedic products, Acharya Ji's Amrit Tattava Vati and Acharya Ji's Oja Amrit Vati, in the domestic market.

15:18 IST BSE
Capacity Expansion

Jeena Sikho Lifecare Capacity Expansion

Jeena Sikho Lifecare postponed its new Lucknow hospital's commercial operations to December 2026 from August. The delay stems from expanded work scope and adverse site weather.

16:28 IST NSE
Business Update

Jeena Sikho Lifecare Business Update

Jeena Sikho Lifecare Limited received NABH accreditation for its Pune hospital, affirming its adherence to quality healthcare standards and operational excellence.

16:36 IST NSE
Product Launch

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare launched two new Ayurvedic products, Jeevanodya Vati and Ojavardhan Vati. This expands the company's portfolio of healthcare and wellness offerings.

17:22 IST NSE
Other Announcement

Jeena Sikho Lifecare Other Announcement

Jeena Sikho Lifecare Limited informed shareholders about the web-link to access its 2025-26 Annual Report and 9th AGM Notice.